NASDAQ · Biotechnology

Viking Therapeutics Inc (VKTX)

$28.38 -3.07%

Add alert

39 In band Daily RSI (14) · 6 Oct 2026

Moving averages

SMA 200$33.45-15.16%

Company profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.

SectorHealthcare

IndustryBiotechnology

Market cap$3.73B

P/E ratioNone

EPS$-4.67

Beta0.679

Dividend yield0.00%

52-week high$43.15

52-week low$22.96

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 43 VRTX Vertex Pharmaceuticals Inc RSI 38 CRSP CRISPR Therapeutics AG RSI 46 IOVA Iovance Biotherapeutics Inc RSI 66 MRNA Moderna Inc RSI 60 SRPT Sarepta Therapeutics Inc RSI 37 EDIT Editas Medicine Inc RSI 49 IBRX ImmunityBio Inc RSI 61 NVAX Novavax Inc RSI 60 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 63

Free forever

RSI alerts for VKTX

Get an email the moment Viking Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 5:10 AM EDT